ScrutarSign up free

REPLIGEN CORP (RGEN)

SEC filings, insider trading & institutional ownership from EDGAR.

NasdaqHealth CareBiotechnology

Couldn’t find the data you were looking for?

We haven’t added REPLIGEN CORP’s filings yet. We add companies and filings all the time.

Track RGEN and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.

Institutions
41
$4.62B held

Latest filings

10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR

All filings →

No filings are available yet.

Top holders

13F & 13D/G • latest quarter

All →
HolderFiledValue
BlackRock, Inc.Aug 7, 2026$734.72M
FMR LLCAug 13, 2026$453.89M
Vanguard Capital ManagementAug 13, 2026$328.98M
Vanguard Portfolio ManagementAug 13, 2026$315.56M
STATE STREET CORPORATIONSep 22, 2026$245.68M

RGEN's filings are public. The insight is one click away.

Scrutar's AI reads every RGEN filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.

Analyze RGEN filingsNo credit cardAI reports included on the free plan

Never miss a RGEN filing.

Get an email when RGEN files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

Data as of Oct 16, 2026Source: SEC EDGAR.